Neurizon Therapeutics has announced a delay in the decision regarding its Investigational New Drug (IND) application, attributing the setback to “strain” within the U.S. Food and...
The U.S. Food and Drug Administration (FDA) has announced the launch of the new “FDA PreCheck” program aimed at strengthening domestic drug manufacturing capabilities. This initiative...
Apellis Pharmaceuticals and Sobi have received a significant boost in their efforts to treat rare kidney diseases, as their drug Empaveli has been granted an expanded...
